Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10000994HBVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TVIS10024344HBVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TVIS10029365HBVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TVIS30010815HIVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TVIS30081188HIVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TVIS30080541HIVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TVIS30058093HIVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TVIS30058094HIVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TVIS30058095HIVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TVIS30058096HIVENSG00000082701.17protein_codingGSK3BYesNo2932P49841
Q6FI27
TCGA Plot Options
Drug Information
GeneGSK3B
DrugBank IDDB12129
Drug NameTideglusib
Target IDBE0001065
UniProt IDP49841
Regulation Typeantagonist
PubMed IDs21760986
CitationsMartinez A, Gil C, Perez DI: Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment. Int J Alzheimers Dis. 2011;2011:280502. doi: 10.4061/2011/280502. Epub 2011 Jun 30.
GroupsInvestigational; Withdrawn
Direct ClassificationNaphthalenes
SMILESO=C1SN(C(=O)N1CC1=CC=CC=C1)C1=C2C=CC=CC2=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL3545157